Proteomedix receives IVDR certification for Proclarix®

Zurich-Schlieren, Switzerland, October 18, 2022. Proteomedix, a Swiss diagnostics company committed to advance prostate cancer care, today announced that is has received IVDR certification for its prostate cancer diagnostic test  Proclarix® from TÜV SÜD. The new In Vitro Diagnostic Regulation (IVDR) recently replaced the IVD Directive. Under the IVDR, diagnostic products are...

read more

Kuros Biosciences Appoints Chris Fair as Chief Operating Officer

Schlieren (Zurich), Switzerland, October 3, 2022 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that it has appointed Chris Fair as Chief Operating Officer (COO). Mr. Fair is a leader in the musculoskeletal and regenerative medicine industry with more than 25...

read more